Sclerosing Encapsulating Peritonitis

Denis J. , Parneau J. , Potel G. , Fontenaille C. , Guenel J. Continuous ambulatory peritoneal dialysis. Ann Int Med 1980; 93: 508.

Slingeneyer A. , Elie M. Cooperative International Study on sclerosing encapsulating peritonitis: Preliminary report. In Advances in Continuous Ambulatory Peritoneal Dialysis. Proceedings of Fifth Annual CAPD Conference, Kansas City, Mo. 1985; pp. 118–23.

Nolph K.D. , Boen F.S.T. , Farrel P.C. , Pyle K.W. Continuous ambulatory peritoneal dialysis in Australia, Europe, and the United States. Kidney Int 1983; 23: 3.

Slingeneyer A. , Mion C. , Mourad G. , Canand B. , Faller B. , Beraud J.J. Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis. Trans Am Soc Artif Intern Organs 1983; 39: 633–40.

Bradley J.A. , McWhinnie D.L. , Hamilton D.N. , Statnes F. Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis (letter). Lancet Jul 9 1983; 2(8341): 113–14.

Rottembourg J. , Gahl G.M. , Poignet J.L. Severe abdominal complications in patients undergoing continuous ambulatory peritoneal dialysis. Proc Eur Dial Transpl Assoc 1983; 20: 236.

Gandhi V.C. , Ing T.S. , Daugirdas J.T. Failure of peritoneal dialysis due to peritoneal sclerosis. Int J Artif Organs 1983; Mar 6(2): 97.

Gandhi V.C. , Humayun H.M. , Ing T.S. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Int Sept 1980; 140(9): 1201–3.

Gokal R. , Ramos J.M. , Ward M.K. , Kerr D.N. Eosinophilic peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1981; Jan 15(6): 328–30.

Lasker N. , Burke J.F. , Patchefsky A. Peritoneal reactions to particular matter in peritoneal dialysis solutions. Trans Am Artif Int Organs 1974; 21: 342–5.

Buckle R.C. , Seabridge C.E. The effect of chlorhexidine in the peritoneal cavity. An experimental study. Lancet 1963; i: 193–5.

Maiorca R. , Cantelupi A. , Cancarini G.C. Prospective control trial of a Y connector and disinfectant to prevent peritonitis in CAPD. Lancet 1983; vol. 2: 642–4.

Binswanger U. , Banmatter F. , Keush G. , Schiffl H. , Koller M. Chemical peritonitis during CAPD. In: Legrain M. , ed. CAPD. Amsterdam: Excerpta Medica, 1980; 238–44.

Shaldon S. , Koch K.M. , Quellhorst E. , Dinarello C.A. Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Intern Organs 1984; 30: 193.

McWhinnie D.L. , Bradley J.A. , Gramwell S.P. Sclerosing peritonitis a further complication of continuous ambulatory peritoneal dialysis. Proceedings of the 3rd International Symposium on Peritoneal Dialysis. Washington DC, June 1984.

Henderson I. , Wilson L. , Wallace M. , Dobbie J.M. Sclerosing peritonitis - An Experimental Study. Proceedings of the 5th Annual CAPD Conference. February 1985. Advances in continuous ambulatory peritoneal dialysis 1985; 107–8.

19 Participating Centers: Factors affecting ultrafiltration in continuous ambulatory peritoneal dialysis: An International Cooperative Study. Periton Dialys Bull 1983; 4: 14–9.

Rubin J. , Nolph K.D. , Arfana D. Comparison of the effects of lactate and acetate on clinical peritoneal clearances. Clin Nephrol 1979; 12: 145.

Miller F. , Nolph K.D. , Joshua I. The osmolality component of peritoneal dialysis solutions. Proc First Int Symp on CAPD. Amsterdam: Excerpta Medica 1979; 12.

Pedersen F.B. , Ryttov N. , Deleuran P. , Dragsholt C. , Kildeberg P. Acetate versus lactate in peritoneal dialysis solutions. Nephron 1985; 39(1): 55–8.

Brown P. , Baddeley H. , Read A.E. , Davies J.D. , McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol), Lancet 1974; 2: 1477.